Table 2.
The levels of myocardial injury markers and the occurrence of AHF and arrhythmia were correlated with NLR.
| NLR | P value | ||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||
| BNP (pg/ml) | 285 (88–1,203) | 362 (100–1,323) | 419 (118–1,340) | 477 (121–1,490) | 0.003 |
| CPK (U/L) | 320 (105–1,067) | 465 (132–1,178) | 690 (171–1,672) | 536 (158–1,540) | 0.032 |
| CK-MB (U/L) | 38 (21–104) | 44 (21–109) | 60 (26–129) | 55 (21–124) | 0.015 |
| HBDH (U/L) | 298 (183–578) | 332 (187–612) | 395 (218–730) | 357 (193–621) | 0.308 |
| AHF, n (%) | 15 (6.0) | 13 (5.3) | 17 (6.9) | 44 (17.7) | <0.001 |
| Arrhythmia, n (%) | 15 (6.0) | 12 (4.9) | 17 (6.9) | 31 (12.5) | 0.007 |
BNP, brain natriuretic peptide; CPK, creatine phosphokinase; CK-MB, creatine kinase-MB; HBDH, hydroxybutyrate dehydrogenase.